GENEVA, March 2 -- NANJING BIOHENG BIOTECH CO., LTD (B1-2, SHUWU Block-16, No. 73 Tanmi Road, Jiangbei New DistrictNanjing, Jiangsu 210061), 南京北恒生物科技有限公司 (中国江苏省南京市江北新区探秘路73号树屋十六栋B1-2) filed a patent application (PCT/CN2025/115488) for "ANTIBODY TARGETING CD33 AND USE THEREOF" on Aug 19, 2025. With publication no. WO/2026/040975, the details related to the patent application was published on Feb 26, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, whic...